Clinical identifiers of complicated Staphylococcus aureus bacteremia

Archives of Internal Medicine

Volumn 163, Issue 17, 2003, Pages 2066-2072

  Fowler Jr , Vance G ^a   Olsen, Maren K ^a   Corey, G Ralph ^a   Woods, Christopher W ^a   Cabell, Christopher H ^a   Reller, L Barth ^a   Cheng, Allen C ^a   Dudley, Tara ^b   Oddone, Eugene Z ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Box 3281 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL ARTHRITIS; BLOOD CULTURE; ENDOCARDITIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SPONDYLITIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STROKE; VALIDATION PROCESS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 0141565300     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.17.2066     Document Type: Article

References (55)

1. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24:584-602.
2. Steinberg JP, Clark CC, Hackman BO. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance. Clin Infect Dis. 1996;23:255-259.
3. Cabell C, Peterson GE, Corey GR, et al. Endocarditis in the 1990s: the effects of a shift in the at-risk population. Arch Intern Med. 2002;162:90-94.
4. Fernandez-Guerrero ML, Verdejo C, Azofra J, de Gorgolas M. Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis. 1995;20:16-23.
5. Sanabria TJ, Alpert JS, Goldberg R, Pape LA, Cheeseman SH. Increasing frequency of staphylococcal infective endocarditis: experience at a university hospital, 1981 through 1988. Arch Intern Med. 1990;150:1305-1309.
6. Sandre RM, Shafran SD. Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis. 1996;22:276-286.
7. Jensen AG, Espersen F, Skinhoj P, Rosdahl VT, Frimodt-Moller N. Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980-1990. J Infect. 1997;34:113-118.
8. Espersen F, Frimodt-Moller N. Staphylococcus aureus endocarditis: review of 119 cases. Arch Intern Med. 1986;146:1118-1121.
9. Jensen AG, Espersen F, Skinhoj P, Frimodt-Moller N. Bacteremic Staphylococcus aureus spondylitis. Arch Intern Med. 1998;158:509-517.
10. Kaplan JE, Palmer DL, Tung KS. Teichoic acid antibody and circulating immune complexes in the management of Staphylococcus aureus bacteremia. Am J Med. 1981;70:769-774.
11. Rahal JJ, Chan YK, Johnson G. Relationship of staphylococcal tolerance, teichoic acid antibody, and serum bactericidal activity to therapeutic outcome in Staphylococcus aureus bacteremia. Am J Med. 1986;81:43-52.
12. Ringberg H, Thoren A, Lilja B. Metastatic complications of Staphylococcus aureus septicemia: to seek is to find. Infection. 2000;28:132-136.
13. Roder BL, Wandall DA, Frimodt-Moller N, Espersen F, Skinhoj P, Rosdahl VT. Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med. 1999;159:462-469.
14. Soderquist B, Sundqvist KG, Jones I, Holmberg H, Vikerfors T. Interleukin-6, C-reactive protein, lactoferrin and white blood cell count in patients with Staphylococcus aureus septicemia. Scand J Infect Dis. 1995;27:375-380.
15. Yzerman EP, Boelens HA, Tjhie JH, Kluytmans JA, Mouton JW, Verbrugh HA. Delta APACHE II for predicting course and outcome of nosocomial Staphylococcus aureus bacteremia and its relation to host defense. J Infect Dis. 1996;173: 914-919.
16. Danner RL, Hartman BJ. Update on spinal epidural abscess: 35 cases and review of the literature. Rev Infect Dis. 1987;9:265-274.
17. Jernigan JA, Farr BM. Short-course therapy of catheter-associated Staphylococcus aureus bacteremia: a meta-analysis. Ann Intern Med. 1993;119:304-311.
18. Darouiche RO, Hamill RJ, Greenberg SB, Weathers SW, Musher DM. Bacterial spinal epidural abscess: review of 43 cases and literature survey. Medicine (Baltimore). 1992;71:369-385.
19. Mylotte JM, Aeschlimann JR, Rotella DL. Staphylococcus aureus bacteremia: factors predicting hospital mortality. Infect Control Hosp Epidemiol. 1996;17:165-168.
20. Mylotte JM, Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis. 2000;31:1170-1174.
21. Nolan CM, Beaty HN. Staphylococcus aureus bacteremia. Am J Med. 1976;60: 495-500.
22. Schonheyder HC, Gottschau A, Friland A, Rosdahl VT. Mortality rate and magnitude of Staphylococcus aureus bacteremia as assessed by a semiquantitative blood culture system. Scand J Infect Dis. 1995;27:19-21.
23. Fowler VG, Sanders LL, Kong LK, et al. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis. 1999;28:106-114.
24. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med. 1985;13:818-829.
25. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-874.
26. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128-140.
27. Libman H, Arbeit RD. Complications associated with Staphylococcus aureus bacteremia. Arch Intern Med. 1984;144:541-545.
28. Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med. 1998;129:862-869.
29. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994;96: 200-209.
30. Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhoj P, Frimodt-Moller N. Treatment and outcome of Staphylococcus aureus bacteremia. Arch Intern Med. 2002;162:25-32.
31. Conterno LO, Wey SB, Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 1998;19:32-37.
32. Harbarth S, Rutschmann O, Sudre F, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med. 1998;158:182-189.
33. Hill PC, Birch M, Chambers S, et al. Prospective study of 424 cases of Staphylococcus aureus bacteraemia. Intern Med J. 2001;31:97-103.
34. Kuikka A, Valtonen VV. Improved outcome of Staphylococcus aureus bacteremia. Infect Dis Clin Pract. 1994;3:282-287.
35. Raad II, Sabbagh MF. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin Infect Dis. 1992; 14:75-82.
36. Roghmann MG. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med. 2000;160:1001-1004.
37. Romero-Vivas J, Rubio M, Fernandez C, Picazo JJ. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1995;21:1417-1423.
38. Soriano A, Martinez JA, Mensa J, et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis. 2000; 30:368-373.
39. Willcox PA, Rayner BL, Whitelaw DA. Community-acquired Staphylococcus aureus bacteraemia in patients who do not abuse intravenous drugs. QJM. 1998; 91:41-47.
40. Harrell FE. Regression Modeling Strategies With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer Verlag NY Inc; 2001.
41. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993; 270:2957-2963.
42. Efron B, Gong G. A leisurely look at the bootstrap, the jackknife, and cross-validation. Am Stat. 1982;36:153-157.
43. Harrell FE, Lee KL, Mark DB. Multivariate prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
44. Hanley JA, McNeill BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
45. Wisplinghoff H, Seifert H, Coimbra M, Wenzel RP, Edmond MB. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Staphylococcus aureus. Clin Infect Dis. 2001;33:733-736.
46. Gonzalez C, Rubio M, Romero-Vivas J, Gonzalez M, Picazo JJ: Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis. 1999;29: 1171-1177.
47. Mekontso-Dessap A, Kirsch M, Brun-Buisson C, Loisance D. Poststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin-susceptible cases. Clin Infect Dis. 2001;32:877-883.
48. McClelland RS, Fowler VG, Sanders LL, et al. Staphylococcus aureus bacteremia among elderly vs younger adult patients: comparison of clinical features and mortality. Arch Intern Med. 1999;159:1244-1247.
49. Fowler V, Li J, Corey G, et al. Role of echocardiography in the evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol. 1997;30:1072-1078.
50. Chang FY, Macdonald BB, Peacock JE, Musher DE, Mylotte JM, Yu VL. Staphylococcus aureus endocarditis: a prospective study in 505 patients with S aureus bacteremia: implications for management. In: Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy; December 16-20, 2001; Chicago, Ill. Abstract L1341.
51. Fang G, Keys TF, Gentry LO, et al. Prosthetic valve endocarditis resulting from nosocomial bacteremia. Ann Intern Med. 1993;119:560-567.
52. Pedersen G, Schonheyder HC. Patients with bacteremia dying before notification of positive blood cultures: a 3-year clinical study. Scand J Infect Dis. 1997; 29:169-173.
53. Ing MB, Baddour LM, Bayer AS. Bacteremia and infective endocarditis: pathogenesis, diagnosis,and complications. In: Crossley KB, Archer GL, eds. The Staphylococci in Human Disease. New York, NY: Churchill Livingstone Inc; 1997:331-354.
54. Lautenschlager S, Herzog C, Zimmerli W. Course and outcome of bacteremia due to Staphylococcus aureus: evaluation of different case definitions. Clin Infect Dis. 1993;16:567-573.
55. Skinner D, Keefer CS. Significance of bacteremia caused by Staphylococcus aureus: a study of one hundred and twenty-two cases and a review of the literature concerned with experimental infection in animals. Arch Intern Med. 1941;68: 851-875.